ANDA 90574, held by Pharmobedient. Cosyntropin.
As of Nov 15, 2026, ANDA 90574 (Cosyntropin), held by Pharmobedient, was first approved by FDA on Dec 17, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 2009 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cosyntropin0.25MG/VIAL ยท injectable;injection | Cosyntropin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters